ALK- rearrangement in non-small-cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ALK- rearrangement in non-small-cell lung cancer (NSCLC)

Published:2018-02-28 Issue:4 Volume:9 Page:423-430
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Du Xue¹^ORCID,Shao Yun¹,Qin Hai-Feng²,Tai Yan-Hong¹,Gao Hong-Jun²

Affiliation:

1. Department of Pathology, Cancer Center of People's Liberation Army of China; Affiliated Hospital of Academy of Military Medical Sciences; Beijing China

2. Department of Lung Cancer, Cancer Center of People's Liberation Army of China; Affiliated Hospital of Academy of Military Medical Sciences; Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12613/fullpdf

Reference78 articles.

1. Translocations involving anaplastic lymphoma kinase (ALK);Duyster;Oncogene,2001

2. Second- and third-generation ALK inhibitors for non-small cell lung cancer;Wu;J Hematol Oncol,2016

3. ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth;Motegi;J Cell Sci,2004

4. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system;Iwahara;Oncogene,1997

5. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkins-lymphoma;Morris;Science,1994

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epinephrine, Pregabalin, and Crizotinib as Three Medicines with Polish Implications over Three Last Centuries and in View of Three Different Drug Discovery Approaches;Biomedicines;2024-09-04

2. Tumor markers in non-small cell lung cancer spine metastasis: an assessment of prognosis and overall survival;European Spine Journal;2024-09-02

3. A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements and Mutations: Implications for Gastric Carcinogenesis and Target Therapy;Current Protein & Peptide Science;2024-09

4. Clinical relevance and druggability of sole reciprocal kinase fusions: A large‐scale study;Cancer Medicine;2024-09

5. Inhibiting the Otub1/phosphorylated STAT3 axis for the treatment of non-small cell lung cancer;Acta Pharmacologica Sinica;2024-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3